Moxatag is the only once-daily amoxicillin formulation available. It is currently approved for the treatment of tonsillitis and/or pharyngitis secondary to Streptococcus pyogenes. Amoxicillin exerts its bactericidal action against susceptible organisms during the stage of multiplication. It acts through the inhibition of biosynthesis of cell wall mucopeptide.
Moxatag is available in 775mg tablets in 30-count bottles.
For more information call (414) 434-6604 or visit Moxatag.com.